Quantcast

Latest P53 Stories

2011-03-31 07:40:00

BEVERLY, Mass., March 31, 2011 /PRNewswire/ -- Cellceutix Corporation (OTCQB: CTIX), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat severe medical conditions including drug-resistant cancers, is pleased to announce that additional research has been concluded on Kevetrin(TM), the Company's flagship cancer compound.

2011-03-29 16:57:41

Protein aggregation, generally associated with Alzheimer’s and mad cow disease, turns out to play a significant role in cancer.

2011-03-21 06:00:00

BEVERLY, Mass., March 21, 2011 /PRNewswire/ -- Cellceutix Corporation (OTCQB: CTIX), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat severe medical conditions including drug-resistant cancers, today announced that it will be presenting a poster titled "Kevetrin(TM), A Novel Small Molecule, Activates p53, Enhances Expression of p21, Induces Cell Cycle Arrest and Apoptosis in a Human Cancer Cell Line" at the American Association for Cancer...

2011-03-15 16:05:36

Jean-Christophe Marine (VIB, K.U.Leuven) strongly argues against the use of Cop1-inhibitory drugs.

2011-03-14 16:21:26

Mutations in three pathways important for suppressing tumors cooperate to launch glioblastoma, an aggressive brain tumor that strikes children and adults.

2011-03-07 15:02:13

Burkitt's lymphoma is one of the most aggressive tumors affecting humans.

2011-03-07 06:00:00

BEVERLY, Mass., March 7, 2011 /PRNewswire/ -- Cellceutix Corporation (OTCQB: CTIX) today reported that its flagship cancer compound, Kevetrin(TM), has demonstrated potent anti-tumor activity in the treatment of leukemia cells in a hematopoietic xenograft tumor model.

2011-03-02 20:32:17

The gene for the protein p53 is the most frequently mutated in human cancer.

2011-03-02 06:12:00

BEVERLY, Mass., March 2, 2011 /PRNewswire/ -- Cellceutix Corporation (Pink Sheets: CTIX) today announced that it has received more data on Kevetrin(TM), the Company's flagship compound for the treatment of cancers.

2011-02-28 15:35:47

A small difference in DNA sequence predicts the degree of disability after a stroke.


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related